Arctic Bioscience
Mindre end 1K følgere
ABS
Euronext Growth Oslo
Food & Beverage
Consumer Goods & Services
Oversigt
Investorkonsensus
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a novel drug candidate for the treatment of patients with mild to moderate psoriasis. Dietary supplements are sold globally as both bulk ingredients and finished products under the ROMEGA brand, to both companies and private customers.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
44,4 mio.
EBIT %
-107,63 %
P/E
-
Udbytteafkast, %
-
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Arctic Bioscience AS: Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation
Arctic Bioscience AS: Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer